The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Clinical trial NCT01739634 · UNKNOWN
Trial details
- NCT number
- NCT01739634
- Sponsor
- Salient Pharmaceuticals Incorporated
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-12-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.